José Ballarín

The MEST score provides earlier risk prediction in lgA nephropathy

Sean J. Barbour, Gabriela Espino-Hernández, Heather N. Reich et al. · Kidney International · 2015 · 279 citations · Full text

Mest Score, Glomerulonephritis, Medicine +7

Clinical Utility of Genetic Testing in Children and Adults with Steroid-Resistant Nephrotic Syndrome

Sheila Santín, Gemma Bullich, Bárbara Tazón‐Vega et al. · Clinical Journal of the American Society of Nephrology · 2011 · 237 citations · Full text

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

Rachel Jones, Thomas F. Hiemstra, José Ballarín et al. · Annals of the Rheumatic Diseases · 2019 · 221 citations · Full text

Association of C4d Deposition with Clinical Outcomes in IgA Nephropathy

Mario Espinosa, Rosa Ortega, Marina Sánchez et al. · Clinical Journal of the American Society of Nephrology · 2014 · 207 citations · Full text